2Seventy Bio Inc(TSVT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

TSVT 2Seventy Bio Inc

Market Closed 04-11 16:00:00 EDT

4.96

+0.00

0.00%

盘后4.97

+0.01+0.20%

16:51 EDT

High4.97	Low4.94	Vol752.75K
Open4.96	D1 Closing4.96	Amplitude0.60%
Mkt Cap259.60M	Tradable Cap212.86M	Total Shares52.34M
T/O3.73M	T/O Rate1.75%	Tradable Shares42.92M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Invest in Global Markets with Tiger Brokers!

Open App

{"stockData":{"symbol":"TSVT","market":"US","secType":"STK","nameCN":"2Seventy Bio Inc","latestPrice":4.96,"timestamp":1744401600000,"preClose":4.96,"halted":0,"volume":752750,"hourTrading":{"tag":"盘后","latestPrice":4.97,"preClose":4.96,"latestTime":"16:51 EDT","volume":912,"amount":4524.5107,"timestamp":1744404689524},"delay":0,"floatShares":42915000,"shares":52338383,"eps":-1.096307,"marketStatus":"Market Closed","change":0,"latestTime":"04-11 16:00:00 EDT","open":4.96,"high":4.97,"low":4.94,"amount":3731667.2680750005,"amplitude":0.006048,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.096307,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1744617600000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":4.96,"preHourTrading":{"tag":"盘前","latestPrice":4.95,"preClose":4.96,"latestTime":"09:29 EDT","volume":2005,"amount":9921.671122,"timestamp":1744378199906},"postHourTrading":{"tag":"盘后","latestPrice":4.97,"preClose":4.96,"latestTime":"16:51 EDT","volume":912,"amount":4524.5107,"timestamp":1744404689524},"volumeRatio":0.3155295549126653,"impliedVol":1.5352,"impliedVolPercentile":0.6853},"requestUrl":"/m/hq/s/TSVT","defaultTab":"news","newsList":[{"id":"2524147294","title":"April 2025's Promising Penny Stock Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2524147294","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524147294?lang=en_us&edition=full_marsco","pubTime":"2025-04-02 01:05","pubTimestamp":1743527121,"startTime":"0","endTime":"0","summary":"As the U.S. market navigates a period of volatility with investors closely monitoring new tariffs and economic indicators, opportunities for growth can still be found in less conventional areas. Penny stocks, despite their somewhat outdated moniker, remain a relevant investment area for those interested in smaller or newer companies that might offer surprising value. By focusing on penny stocks with strong financial foundations, investors may discover potential long-term opportunities that larger firms often overlook.Click here to see the full list of 762 stocks from our US Penny Stocks screener.Overview: 2seventy bio, Inc. is a cell and gene therapy company dedicated to researching, developing, and commercializing cancer treatments in the United States, with a market cap of $259.07 million.Operations: The company generates revenue from its biotechnology segment, amounting to $37.86 million.Assess 2seventy bio's future earnings estimates with our detailed growth reports.Overview: Equit","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/april-2025s-promising-penny-stock-170521615.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BABB","BK4023","BK4526","REIT","BK4021","TUYA","BK4505","SB","BK4509","BK4223","CANG","TTI","BK4563","EQC","TSVT","BK4122","BK4179","BK4194","BK4600","BK4209","BK4214"],"gpt_icon":0},{"id":"2522334048","title":"2seventy bio Q4 Loss Narrows, Revenue Falls","url":"https://stock-news.laohu8.com/highlight/detail?id=2522334048","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522334048?lang=en_us&edition=full_marsco","pubTime":"2025-03-26 04:58","pubTimestamp":1742936281,"startTime":"0","endTime":"0","summary":"2seventy bio  reported a Q4 loss Tuesday of $0.37 per diluted share, narrowing from the loss of $1.11 a year earlier.Four analysts polled by FactSet expected a loss of $0.20.Revenue in the three months ended Dec. 31 fell to $2.93 million from $10.7 million a year earlier.Three analysts surveyed by FactSet projected $13.7 million.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TSVT"],"gpt_icon":0},{"id":"2522880630","title":"2Seventy Bio Q4 Basic EPS USD -0.37","url":"https://stock-news.laohu8.com/highlight/detail?id=2522880630","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522880630?lang=en_us&edition=full_marsco","pubTime":"2025-03-26 04:20","pubTimestamp":1742934019,"startTime":"0","endTime":"0","summary":"Mar 25 (Reuters) - 2Seventy Bio Q4 net income USD -19.519 million.:  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 25-MAR-202520:05:00.503 GMT","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250325:nRSD4zwY2B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TSVT"],"gpt_icon":0},{"id":"2522032887","title":"2seventy bio Q4 2024 GAAP EPS $(0.37) Misses $(0.24) Estimate, Sales $2.926 Miss $12.293M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2522032887","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522032887?lang=en_us&edition=full_marsco","pubTime":"2025-03-26 04:11","pubTimestamp":1742933509,"startTime":"0","endTime":"0","summary":"2seventy bio (NASDAQ:TSVT) reported quarterly losses of $(0.37) per share which missed the analyst consensus estimate of $(0.24) by 54.17 percent. This is a 66.67 percent increase over losses of $(1.11) per share from","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44481435/2seventy-bio-q4-2024-gaap-eps-0-37-misses-0-24-estimate-sales-2-926-miss-12-293m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TSVT"],"gpt_icon":0},{"id":"2522088772","title":"Press Release: 2seventy bio Reports Fourth Quarter and Full Year 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2522088772","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522088772?lang=en_us&edition=full_marsco","pubTime":"2025-03-26 04:05","pubTimestamp":1742933100,"startTime":"0","endTime":"0","summary":"Entered into definitive merger agreement to be acquired by Bristol Myers Squibb at a price of $5.00 per share in an all-cash transaction; expected to close in the second quarter of 2025. 79% reduction in year-over-year net cash spend reflects continued streamlining of cost structure. 2seventy bio, Inc. , today reported financial results and recent highlights for the fourth quarter and full year ended December 31, 2024.On March 10, 2seventy bio announced a definitive merger agreement to be acquired by Bristol Myers Squibb . Under the terms of the agreement, BMS will commence a tender offer to acquire all outstanding shares of 2seventy bio at a price of $5.00 per share in an all-cash transaction. 2seventy bio's Board of Directors unanimously recommends that 2seventy bio stockholders tender their shares in the tender offer.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["R","BK4232","BMS","LU2065731478.USD","IE00B66KJ199.SGD","BK4139","BK4006","IE0031619046.USD","IE00B7SZL793.SGD","IE00B19Z4B17.USD","TSVT","CRS","BK4022"],"gpt_icon":0},{"id":"2519061608","title":"2Seventy Bio Inc  expected to post a loss of 26 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2519061608","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519061608?lang=en_us&edition=full_marsco","pubTime":"2025-03-14 20:36","pubTimestamp":1741955766,"startTime":"0","endTime":"0","summary":"2Seventy Bio Inc  expected to post a loss of26cents a share - Earnings Preview 2Seventy Bio Inc TSVT.OQ TSVT.O is expected to show a rise in quarterly revenue when it reports  results on March 17 (est","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250314:nL8N3PX136:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TSVT"],"gpt_icon":0},{"id":"2519806503","title":"2seventy bio Is Maintained at Equal-Weight by Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2519806503","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519806503?lang=en_us&edition=full_marsco","pubTime":"2025-03-14 20:29","pubTimestamp":1741955340,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TSVT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 14, 2025 08:29 ET (12:29 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4504","BK4534","BK4139","BK4516","LU1668664300.SGD","TSVT","BK4127","LU0006306889.USD","LU0314104364.USD","LU1720051108.HKD","BK4585","LU0267386448.USD","LU0098860793.USD","LU1732800096.USD","LU2089283258.USD","LU1363072403.SGD","LU1720051017.SGD","LU2357305700.SGD","LU1074936037.SGD","LU2133065610.SGD","LU1989772840.SGD","LU0971096721.USD","IE00BZ1G4Q59.USD","LU2111349929.HKD","LU0795875086.SGD","LU1162221912.USD","LU0158827948.USD","LU2089284900.SGD","LU0320765646.SGD","IE00BKVL7J92.USD","LU0106261372.USD","LU2028103732.USD","LU0158827781.USD","BK4588","LU0912757837.SGD","LU2023251221.USD","LU1548497426.USD","LU1989772923.USD","LU1732799900.SGD","LU2271345857.HKD","LU2347655156.SGD","LU0795875169.SGD","LU0225283273.USD","BK4581","LU0106831901.USD"],"gpt_icon":0},{"id":"2518779280","title":"Sector Update: Health Care Stocks Lower in Late Afternoon Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2518779280","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518779280?lang=en_us&edition=full_marsco","pubTime":"2025-03-12 03:58","pubTimestamp":1741723124,"startTime":"0","endTime":"0","summary":"Health care stocks fell late Tuesday afternoon, with the NYSE Health Care Index down 0.8% and the Health Care Select Sector SPDR Fund  shedding 1%.The iShares Biotechnology ETF  dropped 1.2%.In corporate news, 2seventy bio  shares surged nearly 77%. The company said late Monday that it agreed to be acquired by Bristol Myers Squibb  for $5 per share in an all-cash deal valuing it at about $286 million.Tenon Medical  shares jumped 30% after it said late Monday that the European patent office notified the company that two additional patents directed at the Catamaran SI Joint Fixation Device were approved for a grant within the European Community.Guardant Health  shares rose 18% after the Centers for Medicare & Medicaid Services approved Advanced Diagnostic Laboratory Test status for its Shield blood test for colorectal cancer screening.Arvinas  and Pfizer  said a phase 3 trial of vepdegestrant to treat advanced or metastatic breast cancer met its primary endpoint in the estrogen receptor ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1894683348.USD","LU0234572021.USD","LU1093756168.USD","BK4535","GH","LU1066053197.SGD","XLV","SG9999001176.SGD","LU0096364046.USD","SGXZ57979304.SGD","LU1066051498.USD","LU1430594728.SGD","LU0237698245.USD","SG9999002232.USD","BK4532","SG9999013999.USD","TSVT","PFE","BK4581","LU0882574055.USD","IE0002141913.USD","SG9999001176.USD","BK4585","LU0170899867.USD","BK4196","LU1868836757.USD","IE00B19Z3581.USD","LU0225284248.USD","LU0289739699.SGD","PFE.AU","ARVN","IBB","IE00B19Z3B42.SGD","BMY","BK4082","LU2125154935.USD","IE00BLSP4239.USD","IE0009355771.USD","LU2133065610.SGD","LU0321505439.SGD","LU0306806265.USD","LU1670711040.USD","BK4550","BK4533","IE000M9KFDE8.USD","LU1989771016.USD","LU1868836914.USD","BK4534","BK4599","TNON"],"gpt_icon":1},{"id":"2518592777","title":"TSVT Up on Acquisition Agreement With BMY for $286 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2518592777","media":"Zacks","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518592777?lang=en_us&edition=full_marsco","pubTime":"2025-03-12 03:00","pubTimestamp":1741719600,"startTime":"0","endTime":"0","summary":"Shares of 2seventy bio, Inc. TSVT gained 5.26% after the company announced a definitive merger agreement with Bristol Myers Squibb BMY.Per the terms of the deal, BMY will acquire all of the outstanding shares of 2seventy bio for $5.00 per share in an all-cash transaction for a total equity value of approximately $286 million, or $102 million net of estimated cash. The deal represents an 88% premium to TSVT’s closing price of $2.66 on March 7, 2025.Investors cheered the premium offered and shares gained another 3.56% in after-hours trading.In the past year, shares of TVST plunged 40.8% compared with the industry’s 7.2% decline.However, TSVT has been facing challenges for quite some time now and is looking to maximize shareholder value.However, in September 2024, TSVT and BMY announced the discontinuation of enrollment in their ongoing phase III KarMMa-9 study evaluating Abecma with lenalidomide maintenance versus lenalidomide maintenance alone in patients with newly diagnosed multiple m","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/tsvt-acquisition-agreement-bmy-286-190000167.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","IE00BKVL7J92.USD","LU1032466523.USD","TSVT","LU1718418525.SGD","IE0002141913.USD","LU0114720955.EUR","IE00B2B36J28.USD","LU0096364046.USD","LU1868837136.USD","BMY","LU1989771016.USD","LU2242652126.USD","BK4599","LU0237698245.USD","LU0321505439.SGD","LU0823416689.USD","LU2360032135.SGD","LU0321505868.SGD","LU2089984988.USD","LU0109394709.USD","LU1093756325.SGD","LU2023250504.SGD","IE00BZ1G4Q59.USD","LU1868836757.USD","IE00BFTCPJ56.SGD","LU0882574055.USD","LU2362541513.USD","LU0306806265.USD","LU1670710588.SGD","LU1917777945.USD","BK4532","LU0225284248.USD","IE00BJT1NW94.SGD","BK4559","REGN","BK4588","LU1868836914.USD","LU1291159041.SGD","BK4585","LU2468319806.SGD","LU2242646821.SGD","BK4581","LU1571399168.USD","LU1323610961.USD","LU0058720904.USD","LU1670711123.USD","LU2106854487.HKD","LU0320765992.SGD"],"gpt_icon":1},{"id":"2518720128","title":"BUZZ-U.S. STOCKS ON THE MOVE-Elevance, Backblaze, Disney","url":"https://stock-news.laohu8.com/highlight/detail?id=2518720128","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518720128?lang=en_us&edition=full_marsco","pubTime":"2025-03-12 01:57","pubTimestamp":1741715875,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Elevance, Backblaze, DisneyEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: https:","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250311:nL4N3PU10Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCRX","LU2362540622.SGD","NFE","LU0106261372.USD","LZMH","BLZE","ALKT","AMAL","ELV","EXPE","NVAX","RELY","TSVT","AAL","SEZL","CAR","STLD","LU1983299246.USD","TER","EWCZ","CENX","HUT","MASS","LEGN","TSYW.SI","ARVN","RAY","BK4534","LFMD","LU2063271972.USD","SYRS","BK4211","LU0957791311.USD","LU0053671581.USD","LU0320765489.SGD","WCT","BVS","MLYS","LYFT","HTZ","UAL","LU0058720904.USD","WYNN","ILMN","LU2237957811.SGD","COEP"],"gpt_icon":1},{"id":"2518729175","title":"Crude Oil Gains 1%; Ciena Earnings Top Views","url":"https://stock-news.laohu8.com/highlight/detail?id=2518729175","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518729175?lang=en_us&edition=full_marsco","pubTime":"2025-03-12 00:02","pubTimestamp":1741708973,"startTime":"0","endTime":"0","summary":" ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44254319/crude-oil-gains-1-ciena-earnings-top-views","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["METC","CIEN","TSVT","ARVN","SPGC","ASAN","NWTG"],"gpt_icon":1},{"id":"2518771882","title":"Deals of the day-Mergers and acquisitions","url":"https://stock-news.laohu8.com/highlight/detail?id=2518771882","media":"Reuters","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518771882?lang=en_us&edition=full_marsco","pubTime":"2025-03-11 21:39","pubTimestamp":1741700391,"startTime":"0","endTime":"0","summary":"Deals of the day-Mergers and acquisitionsAdds: Gjensidige Forsikring, Rosebank Industries, AgeasMarch 11 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 2000 GMT o","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250311:nL6N3PU0LH:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0096364046.USD","LU1670711123.USD","IE00BJT1NW94.SGD","IE00B19Z8X17.USD","IE00B2B36J28.USD","LU1093756168.USD","BK4581","LU1323610961.USD","LU0456855351.SGD","BK4588","LU1868836591.USD","LU1670711040.USD","LU1093756325.SGD","LU2357125470.USD","LU2125154935.USD","LU0823414478.USD","LU2360032135.SGD","LU1430594728.SGD","LU1868836914.USD","LU2249611893.SGD","TSVT","LU0957791311.USD","LU1861219969.SGD","BK4543","LU1261432733.SGD","BK4585","IE00BSNM7G36.USD","IE0009355771.USD","LU1989771016.USD","LU1868837300.USD","IE00BJJMRZ35.SGD","IE00BGHQF417.EUR","LU1032466523.USD","LU2242652126.USD","LU0985481810.HKD","LU2125154778.USD","LU2506951792.HKD","LU0237698245.USD","LU2133065610.SGD","BK4559","IE00BKVL7J92.USD","LU0321505868.SGD","BMY","LU1074936037.SGD","LU0096362180.USD","LU0061475181.USD","ETN","BK4096","LU0306807586.USD","IE00B2PGVK34.USD"],"gpt_icon":0},{"id":"2518740288","title":"2seventy bio Shares up 76% as Bristol Myers Squibb Acquires Co for About $286 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2518740288","media":"THOMSON REUTERS","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518740288?lang=en_us&edition=full_marsco","pubTime":"2025-03-11 21:37","pubTimestamp":1741700250,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250311:nFWN3PU13C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TSVT","BK4139"],"gpt_icon":0},{"id":"2518741753","title":"2seventy bio (TSVT) was downgraded to a Hold Rating at Leerink Partners","url":"https://stock-news.laohu8.com/highlight/detail?id=2518741753","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518741753?lang=en_us&edition=full_marsco","pubTime":"2025-03-11 21:37","pubTimestamp":1741700226,"startTime":"0","endTime":"0","summary":"In a report released today, Daina Graybosch from Leerink Partners downgraded 2seventy bio (TSVT – Research Report) to a Hold, with a price target o...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/2seventy-bio-tsvt-was-downgraded-to-a-hold-rating-at-leerink-partners?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/2seventy-bio-tsvt-was-downgraded-to-a-hold-rating-at-leerink-partners?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TSVT"],"gpt_icon":0},{"id":"2518666745","title":"2seventy bio Cut to Market Perform From Outperform by Leerink Partners","url":"https://stock-news.laohu8.com/highlight/detail?id=2518666745","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518666745?lang=en_us&edition=full_marsco","pubTime":"2025-03-11 20:30","pubTimestamp":1741696200,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TSVT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 11, 2025 08:30 ET (12:30 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TSVT"],"gpt_icon":0},{"id":"2518712574","title":"Leerink Partners Downgrades 2seventy Bio to Market Perform From Outperform, Adjusts Price Target to $5 From $9","url":"https://stock-news.laohu8.com/highlight/detail?id=2518712574","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518712574?lang=en_us&edition=full_marsco","pubTime":"2025-03-11 19:09","pubTimestamp":1741691376,"startTime":"0","endTime":"0","summary":"2seventy Bio (TSVT) has an average rating of Hold and mean price target of $5.67, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TSVT"],"gpt_icon":0},{"id":"1107691437","title":"Bristol Myers to Buy Collaborator 2Seventy Bio for $286 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=1107691437","media":"Investing.com","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107691437?lang=en_us&edition=full_marsco","pubTime":"2025-03-11 18:55","pubTimestamp":1741690500,"startTime":"0","endTime":"0","summary":"Bristol-Myers Squibb Company  will buy 2Seventy Bio Inc - a firm it has collaborated with in developing cancer treatments- for about $286 million, 2seventy said in a statement on Monday evening.2Seventy Bio shares soared 76.4% in premarket trading Tuesday.2seventy said it had entered a definitive merger agreement with Bristol Myers, under which the biopharmaceutical giant will offer $5 for each share in 2seventy. The figure represents an 78.6% premium to 2seventy’s Monday close of $2.80.The two ","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.investing.com/news/stock-market-news/bristol-myers-to-buy-collaborator-2seventy-bio-for-286-mln-3919477","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Bristol Myers to Buy 2Seventy Bio for $286 Mln","news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"investingArticles_highlight","symbols":["TSVT","BMY"],"gpt_icon":1},{"id":"2518714552","title":"US Stocks Likely To Open Higher After Monday's Selloff: TSLA Stock Rebounds From Its Worst Fall In 5 Years After Trump Backs Musk, Analyst Says 'Pullbacks Are Normal'","url":"https://stock-news.laohu8.com/highlight/detail?id=2518714552","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518714552?lang=en_us&edition=full_marsco","pubTime":"2025-03-11 18:52","pubTimestamp":1741690379,"startTime":"0","endTime":"0","summary":"U.S. stock futures rose on Tuesday following Monday&#39;s heavy selloff. Futures of all four benchmark indices surged in premarket trading.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/government/regulations/25/03/44242600/us-stocks-likely-to-open-higher-after-mondays-selloff-tsla-stock-rebounds-from-its-worst-fall-in-5-years-after-trump-backs-musk-analyst-says-pullbacks-are-normal","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SQQQ","TSVT","LU1066051225.USD","KSS","QLD","BK4507","IVV","TNON","UNFI","ESmain","NVIW.SI","USJW.SI","MNQmain","LU2087621335.USD","SDS","ASAN","SH","NQmain","LU0321505868.SGD",".SPX","LU2403377893.USD","OEX","SPY","CIEN","OEF","UPRO","TQQQ","TSLA","SG9999001077.SGD","LU1291159041.SGD","SSO","TSYW.SI","QID","BMY","SPXU","USAW.SI","LU2505996681.GBP","VOO","DKS","PSQ","LFMD","LU2463028550.USD","NPWR",".IXIC","BK4561"],"gpt_icon":1},{"id":"2518144627","title":"2seventy Bio downgraded to Market Perform from Outperform at Leerink","url":"https://stock-news.laohu8.com/highlight/detail?id=2518144627","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518144627?lang=en_us&edition=full_marsco","pubTime":"2025-03-11 18:50","pubTimestamp":1741690233,"startTime":"0","endTime":"0","summary":"Leerink downgraded 2seventy Bio (TSVT) (TVST) to Market Perform from Outperform with a price target of $5, down from $9, to reflect the pending tak...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/2seventy-bio-downgraded-to-market-perform-from-outperform-at-leerink-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/2seventy-bio-downgraded-to-market-perform-from-outperform-at-leerink-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","TSVT"],"gpt_icon":0},{"id":"2518715577","title":"2seventy Bio Shares Soar Premarket on Deal to be Acquired by Bristol Myers","url":"https://stock-news.laohu8.com/highlight/detail?id=2518715577","media":"Dow Jones","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518715577?lang=en_us&edition=full_marsco","pubTime":"2025-03-11 17:58","pubTimestamp":1741687080,"startTime":"0","endTime":"0","summary":"Shares of 2seventy bio took flight Tuesday after the biotechnology company agreed to be acquired by partner Bristol Myers Squibb.Bristol Myers is paying $5 a share in cash for 2seventy, a 79% premium to Monday's closing price of $2.80 for the Cambridge, Mass., company.The deal, slated to close in the second quarter, carries a total equity value of about $286 million, or $102 million net of 2seventy's estimated cash.2seventy shares were recently up 77% to $4.95 in premarket trading.Princeton, N.J., biopharmaceutical company Bristol Myers and 2seventy are partners on the gene therapy Abecma, which is approved in the U.S. for adults with the blood cancer multiple myeloma.The companies are jointly developing and commercializing Abecma in the U.S., with Bristol Myers responsible for manufacturing and commercialization outside of the U.S.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0306806265.USD","LU1670710661.SGD","LU2242652126.USD","BK4534","LU0985481810.HKD","LU1718418525.SGD","BK4581","MYE","LU0456855351.SGD","LU1989771016.USD","LU1093756168.USD","LU1323610961.USD","LU1585245621.USD","LU1868836591.USD","IE00BFTCPJ56.SGD","LU2360032135.SGD","LU1868837300.USD","LU2125154778.USD","LU1093756325.SGD","LU0237698245.USD","BK4532","BMY","IE00B2B36J28.USD","LU2242646821.SGD","BK4139","IE0009355771.USD","IE00BJT1NW94.SGD","IE00BFXG1179.USD","IE00BJJMRZ35.SGD","BK4007","LU0225771236.USD","BK4126","LU0321505868.SGD","LU1670711123.USD","LU0225284248.USD","LU2125154935.USD","LU1291159041.SGD","IE0002141913.USD","LU0114720955.EUR","LU0061475181.USD","LU0868494617.USD","LU1261432733.SGD","BK4588","LU2133065610.SGD","LU0321505439.SGD","LU1868836914.USD","TSVT","LU1074936037.SGD","LU1868837136.USD","LU0096364046.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.2seventybio.com","stockEarnings":[{"period":"1week","weight":0.002},{"period":"1month","weight":0.002},{"period":"3month","weight":0.992},{"period":"6month","weight":-0.01},{"period":"1year","weight":-0.1014},{"period":"ytd","weight":0.6871}],"compareEarnings":[{"period":"1week","weight":0.0567},{"period":"1month","weight":-0.0446},{"period":"3month","weight":-0.0802},{"period":"6month","weight":-0.0787},{"period":"1year","weight":0.0308},{"period":"ytd","weight":-0.089}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. The company's products pipeline includes Abecma, a chimeric antigen receptor T-cell product candidates for the treatment of multiple myeloma. It has a collaboration arrangement with Bristol Myers Squibb Company. The company was incorporated in 2021 and is headquartered in Cambridge, Massachusetts.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.072098},{"month":2,"riseRate":0.25,"avgChangeRate":-0.052269},{"month":3,"riseRate":0.75,"avgChangeRate":0.201442},{"month":4,"riseRate":0.25,"avgChangeRate":-0.10557},{"month":5,"riseRate":0.333333,"avgChangeRate":0.033749},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.058538},{"month":7,"riseRate":0.666667,"avgChangeRate":0.022042},{"month":8,"riseRate":0.666667,"avgChangeRate":-0.086933},{"month":9,"riseRate":0,"avgChangeRate":-0.095907},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.122217},{"month":11,"riseRate":0,"avgChangeRate":-0.216501},{"month":12,"riseRate":0.25,"avgChangeRate":0.160295}],"exchange":"NASDAQ","name":"2Seventy Bio Inc","nameEN":"2Seventy Bio Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.32.4","shortVersion":"4.32.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"2Seventy Bio Inc(TSVT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest 2Seventy Bio Inc(TSVT) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"2Seventy Bio Inc,TSVT,2Seventy Bio Inc股票,2Seventy Bio Inc股票老虎,2Seventy Bio Inc股票老虎国际,2Seventy Bio Inc行情,2Seventy Bio Inc股票行情,2Seventy Bio Inc股价,2Seventy Bio Inc股市,2Seventy Bio Inc股票价格,2Seventy Bio Inc股票交易,2Seventy Bio Inc股票购买,2Seventy Bio Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"2Seventy Bio Inc(TSVT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest 2Seventy Bio Inc(TSVT) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction